🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 11 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/11/2018 138,99 143,45 132,57 137,18 -1,68% 7,83% 841.900
05/11/2018 146,84 147,27 137,40 139,53 -4,41% 6,72% 1.034.500
02/11/2018 142,02 148,72 141,01 145,97 +2,80% 5,43% 1.027.700
01/11/2018 134,17 142,23 132,53 141,99 +6,15% 7,23% 976.800
31/10/2018 127,85 134,74 127,46 133,76 +7,50% 5,69% 1.374.900
30/10/2018 116,75 124,64 115,33 124,43 +6,46% 7,97% 1.097.600
29/10/2018 123,39 124,67 113,71 116,88 -4,49% 8,88% 1.111.100
26/10/2018 121,84 126,05 116,75 122,37 -2,49% 7,63% 996.500
25/10/2018 125,22 129,06 120,01 125,49 +1,99% 7,23% 1.529.900
24/10/2018 133,24 134,39 120,74 123,04 -8,40% 10,24% 1.717.700
23/10/2018 129,00 135,61 127,04 134,32 +1,33% 6,64% 1.341.100
22/10/2018 134,92 134,92 129,00 132,56 -1,24% 4,39% 777.000
19/10/2018 139,68 140,03 133,38 134,22 -3,30% 4,76% 678.200
18/10/2018 141,65 142,30 135,84 138,80 -2,25% 4,56% 758.300
17/10/2018 139,49 142,25 138,63 141,99 +2,46% 2,60% 764.700
16/10/2018 132,56 139,32 132,56 138,58 +5,51% 5,10% 874.800
15/10/2018 130,28 133,73 126,05 131,34 +0,64% 5,89% 740.000
12/10/2018 126,81 131,00 125,31 130,50 +6,96% 4,49% 1.378.100
11/10/2018 119,50 127,88 116,74 122,01 -0,24% 9,32% 1.206.700
10/10/2018 128,86 128,92 122,16 122,30 -5,32% 5,25% 1.272.300
09/10/2018 129,84 132,75 127,60 129,17 -1,46% 3,97% 697.000
08/10/2018 134,25 135,55 128,71 131,08 -2,93% 5,09% 981.800
05/10/2018 143,01 143,99 130,37 135,03 -5,47% 9,52% 2.290.300
04/10/2018 151,00 151,59 141,24 142,84 -3,08% 6,85% 2.790.000
03/10/2018 142,44 149,97 136,10 147,38 +3,48% 9,74% 2.060.700
02/10/2018 148,51 149,99 140,89 142,42 -4,26% 6,13% 2.360.600
01/10/2018 164,50 165,87 148,04 148,76 -7,89% 10,84% 2.145.800
28/09/2018 158,83 161,66 157,43 161,51 +1,42% 2,66% 1.023.100
27/09/2018 158,47 160,70 158,21 159,25 +0,28% 1,57% 775.100
26/09/2018 157,00 161,49 155,94 158,80 +2,74% 3,54% 1.198.900